Previous 10 | Next 10 |
Moderna Advances its Mid stage Covid 19 Trial Moderna Inc (MRNA) provided an update about its Phase II clinical trial of Covid 19 vaccine candidate. The company reported that it has completed the patient enrollment for both the cohort of the trial. Moderna has already completed the Phase...
Initiation of pivotal PURSUIT trial is targeted for Q4 2020 following pending results from Company's SUI feasibility study, which is evaluating a new sham treatment tip PURSUIT clearance and pending results from the SUI feasibility study are significant milestones in Company's pursuit o...
Meeting scheduled to reconvene July 22, 2020 at 10:30 AM Eastern Time ENGLEWOOD, CO / ACCESSWIRE / June 29, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it has adjourned its 2020 Annual Meeting of Stoc...
Viveve Medical, Inc. (VIVE) Q1 2020 Earnings Conference Call May 14, 2020 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Scott Durbin - Chief Executive Officer Conference Call Participants Presentation Operator Good afterno...
Viveve Medical (NASDAQ: VIVE ): Q1 GAAP EPS of -$0.82 beats by $11.78 . Revenue of $1.3M (-56.8% Y/Y) beats by $0.19M . Shares -2.4% . Press Release More news on: Viveve Medical, Inc., Earnings news and commentary, Healthcare stocks news, ,
First quarter continued to demonstrate success of the recurring revenue model Organization focused on advancing stress urinary incontinence clinical strategy Company to host conference call at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / May 14, 2020 / Viveve Medical, Inc. (NASDA...
ENGLEWOOD, CO / ACCESSWIRE / May 7, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will provide a corporate update and report its first quarter 2020 financial results after the close of the U.S. financial ma...
Reconfirms plans for near-term focus on Stress Urinary Incontinence clinical strategy Announces plans to further reduce operating expenses and cash burn rate Strengthens balance sheet through warrant exercise for approximately $3 million in proceeds ENGLEWOOD, CO / ACCESSWIRE /...
ENGLEWOOD, CO / ACCESSWIRE / April 17, 2020 / Viveve Medical, Inc. ("Viveve") (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it has entered into agreements with several institutional and accredited investors to exercise certain outstandin...
Viveve 2.0 System now available throughout North America, Asia, and over 30 European countries ENGLEWOOD, CO / ACCESSWIRE / April 16, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced it has received regulatory cl...
News, Short Squeeze, Breakout and More Instantly...
Novonix Limited (NVNXF) is expected to report for quarter end 2023-12-31 MedAvail Holdings Inc. (MDVL) is expected to report for Q3 2023 Nobility Homes, Inc. (NOBH) is expected to report for quarter end 2023-10-31 Walgreens Boots Alliance Inc. (WBA) is expected to report $0.66 for Q1 ...
Disco Corporation ADR (DSCSY) is expected to report for Q2 2024 Sonic Foundry Inc. (SOFO) is expected to report for quarter end 2023-09-30 Sono Group N.V. (SEVCQ) is expected to report for quarter end 2023-09-30 Minim Inc (MINM) is expected to report for Q3 2023 Enel Spa ADR (ENLA...
Enel Spa ADR (ENLAY) is expected to report for Q3 2023 LEG Immobilien SE Registered Shares (LEGIF) is expected to report for Q3 2023 G. Willi-Food International Ltd. (WILC) is expected to report for Q3 2023 Worthington Steel Inc. (WS) is expected to report $0.15 for Q2 2024 Sonic ...